Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Synthesis of Infectious Bacteriophages in an E. coli-based Cell-free Expression System.

Rustad M, Eastlund A, Marshall R, Jardine P, Noireaux V.

J Vis Exp. 2017 Aug 17;(126). doi: 10.3791/56144.

PMID:
28872145
2.

The Interprofessional Collaborative Competency Attainment Survey (ICCAS): A replication validation study.

Schmitz CC, Radosevich DM, Jardine P, MacDonald CJ, Trumpower D, Archibald D.

J Interprof Care. 2017 Jan;31(1):28-34. Epub 2016 Nov 16.

PMID:
27849422
3.

Basal ganglia necrosis: a 'best-fit' approach.

Boca M, Lloyd K, Likeman M, Jardine P, Whone A.

Pract Neurol. 2016 Dec;16(6):458-461. doi: 10.1136/practneurol-2016-001410. Epub 2016 Aug 8.

PMID:
27503951
4.

Dynamic Succession of Groundwater Functional Microbial Communities in Response to Emulsified Vegetable Oil Amendment during Sustained In Situ U(VI) Reduction.

Zhang P, Wu WM, Van Nostrand JD, Deng Y, He Z, Gihring T, Zhang G, Schadt CW, Watson D, Jardine P, Criddle CS, Brooks S, Marsh TL, Tiedje JM, Arkin AP, Zhou J.

Appl Environ Microbiol. 2015 Jun 15;81(12):4164-72. doi: 10.1128/AEM.00043-15. Epub 2015 Apr 10.

5.

Clinical onset and course, response to treatment and outcome in 24 patients with the cblE or cblG remethylation defect complemented by genetic and in vitro enzyme study data.

Huemer M, Bürer C, Ješina P, Kožich V, Landolt MA, Suormala T, Fowler B, Augoustides-Savvopoulou P, Blair E, Brennerova K, Broomfield A, De Meirleir L, Gökcay G, Hennermann J, Jardine P, Koch J, Lorenzl S, Lotz-Havla AS, Noss J, Parini R, Peters H, Plecko B, Ramos FJ, Schlune A, Tsiakas K, Zerjav Tansek M, Baumgartner MR.

J Inherit Metab Dis. 2015 Sep;38(5):957-67. doi: 10.1007/s10545-014-9803-7. Epub 2014 Dec 20.

PMID:
25526710
6.

Genome replication, synthesis, and assembly of the bacteriophage T7 in a single cell-free reaction.

Shin J, Jardine P, Noireaux V.

ACS Synth Biol. 2012 Sep 21;1(9):408-13. doi: 10.1021/sb300049p. Epub 2012 Jul 10.

PMID:
23651338
7.

Long-Term Follow-up of a Successfully Treated Case of Congenital Pyridoxine-Dependent Epilepsy.

Proudfoot M, Jardine P, Straukiene A, Noad R, Parrish A, Ellard S, Weatherby S.

JIMD Rep. 2013;10:103-6. doi: 10.1007/8904_2012_210. Epub 2013 Feb 12.

8.

Novel deletion of lysine 7 expands the clinical, histopathological and genetic spectrum of TPM2-related myopathies.

Davidson AE, Siddiqui FM, Lopez MA, Lunt P, Carlson HA, Moore BE, Love S, Born DE, Roper H, Majumdar A, Jayadev S, Underhill HR, Smith CO, von der Hagen M, Hubner A, Jardine P, Merrison A, Curtis E, Cullup T, Jungbluth H, Cox MO, Winder TL, Abdel Salam H, Li JZ, Moore SA, Dowling JJ.

Brain. 2013 Feb;136(Pt 2):508-21. doi: 10.1093/brain/aws344.

9.

SGCE mutations cause psychiatric disorders: clinical and genetic characterization.

Peall KJ, Smith DJ, Kurian MA, Wardle M, Waite AJ, Hedderly T, Lin JP, Smith M, Whone A, Pall H, White C, Lux A, Jardine P, Bajaj N, Lynch B, Kirov G, O'Riordan S, Samuel M, Lynch T, King MD, Chinnery PF, Warner TT, Blake DJ, Owen MJ, Morris HR.

Brain. 2013 Jan;136(Pt 1):294-303. doi: 10.1093/brain/aws308.

10.

Childhood presentation of COL4A1 mutations.

Shah S, Ellard S, Kneen R, Lim M, Osborne N, Rankin J, Stoodley N, van der Knaap M, Whitney A, Jardine P.

Dev Med Child Neurol. 2012 Jun;54(6):569-74. doi: 10.1111/j.1469-8749.2011.04198.x. Epub 2012 Jan 16. Review.

11.

Paediatric UK demyelinating disease longitudinal study (PUDDLS).

Absoud M, Cummins C, Chong WK, De Goede C, Foster K, Gunny R, Hemingway C, Jardine P, Kneen R, Likeman M, Lim MJ, Pike M, Sibtain N, Whitehouse WP, Wassmer E.

BMC Pediatr. 2011 Jul 28;11:68. doi: 10.1186/1471-2431-11-68.

12.

A limited microbial consortium is responsible for extended bioreduction of uranium in a contaminated aquifer.

Gihring TM, Zhang G, Brandt CC, Brooks SC, Campbell JH, Carroll S, Criddle CS, Green SJ, Jardine P, Kostka JE, Lowe K, Mehlhorn TL, Overholt W, Watson DB, Yang Z, Wu WM, Schadt CW.

Appl Environ Microbiol. 2011 Sep;77(17):5955-65. doi: 10.1128/AEM.00220-11. Epub 2011 Jul 15.

13.

Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study.

Kurian MA, Li Y, Zhen J, Meyer E, Hai N, Christen HJ, Hoffmann GF, Jardine P, von Moers A, Mordekar SR, O'Callaghan F, Wassmer E, Wraige E, Dietrich C, Lewis T, Hyland K, Heales S Jr, Sanger T, Gissen P, Assmann BE, Reith ME, Maher ER.

Lancet Neurol. 2011 Jan;10(1):54-62. doi: 10.1016/S1474-4422(10)70269-6. Epub 2010 Nov 25.

14.

A new method to detect loss of heterozygosity using cohort heterozygosity comparisons.

Green MR, Jardine P, Wood P, Wellwood J, Lea RA, Marlton P, Griffiths LR.

BMC Cancer. 2010 May 12;10:195. doi: 10.1186/1471-2407-10-195.

15.

Dopa responsive dystonia.

Low K, Harding T, Jardine P.

BMJ. 2010 Mar 4;340:c668. doi: 10.1136/bmj.c668. No abstract available.

PMID:
20203076
16.

Very long chain fatty acid levels in patients diagnosed with multiple sclerosis.

Wilkins A, Ingram G, Brown A, Jardine P, Steward CG, Robertson NP, Scolding NJ.

Mult Scler. 2009 Dec;15(12):1525-7. doi: 10.1177/1352458509351731. Epub 2009 Nov 13.

PMID:
19965514
17.

Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia.

Kurian MA, Zhen J, Cheng SY, Li Y, Mordekar SR, Jardine P, Morgan NV, Meyer E, Tee L, Pasha S, Wassmer E, Heales SJ, Gissen P, Reith ME, Maher ER.

J Clin Invest. 2009 Jun;119(6):1595-603. doi: 10.1172/JCI39060. Epub 2009 May 26.

18.

A dominantly inherited mutation in collagen IV A1 (COL4A1) causing childhood onset stroke without porencephaly.

Shah S, Kumar Y, McLean B, Churchill A, Stoodley N, Rankin J, Rizzu P, van der Knaap M, Jardine P.

Eur J Paediatr Neurol. 2010 Mar;14(2):182-7. doi: 10.1016/j.ejpn.2009.04.010. Epub 2009 May 28.

PMID:
19477666
19.

Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease.

Nicolino M, Byrne B, Wraith JE, Leslie N, Mandel H, Freyer DR, Arnold GL, Pivnick EK, Ottinger CJ, Robinson PH, Loo JC, Smitka M, Jardine P, Tatò L, Chabrol B, McCandless S, Kimura S, Mehta L, Bali D, Skrinar A, Morgan C, Rangachari L, Corzo D, Kishnani PS.

Genet Med. 2009 Mar;11(3):210-9. doi: 10.1097/GIM.0b013e31819d0996.

PMID:
19287243
20.

High frequency stimulation of the mamillothalamic tract for the treatment of resistant seizures associated with hypothalamic hamartoma.

Khan S, Wright I, Javed S, Sharples P, Jardine P, Carter M, Gill SS.

Epilepsia. 2009 Jun;50(6):1608-11. doi: 10.1111/j.1528-1167.2008.01995.x. Epub 2009 Feb 23.

Supplemental Content

Loading ...
Support Center